A drug that is currently used for cancer could be the key in treating a disease that has no cure, and a life expectancy of ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The European Medicines Agency has recommended marketing approval for Alyftrek for cystic fibrosis and Attrogy for a form of ...

Environmental and Occupational Exposure: Chronic inhalation of inorganic and organic particulates, such as silica, asbestos, ...

Pulmonary fibrosis (PF) is a progressive interstitial lung disease (ILD) characterized by excessive fibrotic tissue ...

Introduction Interstitial lung disease (ILD) patients may develop a progressive phenotype usually characterised by ...

Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis has demonstrated benefits of an investigational, once-a-day pill called brenso catib as ...